EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation and Modulation of Gut Microbiome Dysfunction in Chronically Critically Ill Patients: A Prospective Pilot Study

Ekaterina Chernevskaya iD, Ekaterina Sorokina, Petr Polyakov iD, Kirill Gorshkov, Nadezda Kovaleva, Vladislav Zakharchenko, Natalia Beloborodova iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ekaterina Chernevskaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Petrovka Str., Moscow 107031, Russia. Hauptthemen laut MEDLINE: Critical Illness, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Assessing gut microbiota disturbances for subsequent modulation remains a challenge. This study aims to evaluate the safety and efficacy of a microbiota-oriented strategy in treating patients with chronic critical illness (CCI). This single-center prospective study included chronically critically ill patients, stratified into three groups by severity of microbiota dysfunction. Three different microbiota modulation regimens including metabiotics, enteral, and anaerobic-safe systemic antibiotics were applied subsequently. Forty-three patients with chronic critical illness were included. Mild microbiota dysfunction was present in 49% patients, moderate in 19% and severe in 32%. Monitoring of biomarkers for 14 days confirmed the safety of reducing the pharmacological load in mild to moderate microbiota dysfunction. The microbiota-oriented strategy demonstrated improvements in neurological condition, a decrease in inflammation, and normalization of several hematological and biochemical parameters, without contributing to the activation of opportunistic microorganisms in the intestinal microbiota. The incidence of pneumonia in patients with CCI was reduced significantly during the 28-day observation period. The results of the pilot study suggest the potential benefits of a microbiota-oriented strategy in preventing nosocomial pneumonia in CCI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessGastrointestinal MicrobiomeHumansPilot ProjectsMaleFemaleProspective StudiesMiddle AgedAgedAnti-Bacterial AgentsChronic DiseaseAdult

Stichwörter der Autor:innen

aromatic microbial metabolitesbiomarkerschronic critical illnessmetabioticsmicrobiomemicrobiota

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Petrovka Str., Moscow 107031, Russia.

ORCID-Profile: Ekaterina Chernevskaya, Petr Polyakov, Natalia Beloborodova

Zitieren

APA

Chernevskaya, E., Sorokina, E., Polyakov, P., Gorshkov, K., Kovaleva, N., Zakharchenko, V., & Beloborodova, N. (2025). Evaluation and Modulation of Gut Microbiome Dysfunction in Chronically Critically Ill Patients: A Prospective Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199778

Vancouver

Chernevskaya E, Sorokina E, Polyakov P, Gorshkov K, Kovaleva N, Zakharchenko V, et al. Evaluation and Modulation of Gut Microbiome Dysfunction in Chronically Critically Ill Patients: A Prospective Pilot Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199778

BibTeX
@article{Chernevskaya2025,
  author = {Chernevskaya, Ekaterina and Sorokina, Ekaterina and Polyakov, Petr and Gorshkov, Kirill and Kovaleva, Nadezda and Zakharchenko, Vladislav and Beloborodova, Natalia},
  title = {Evaluation and Modulation of Gut Microbiome Dysfunction in Chronically Critically Ill Patients: A Prospective Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199778}
}
Kostenlos starten →